60 min
On-site
Mon., May. 19 11:00 (UTC)
Lunch Workshop 3 Room B

Innovation in neurology patient management: Blood-based biomarkers and the role of Neurofilament Light Chain (NfL) in relapsing multiple sclerosis (RMS)

About this session

  • Intro: Dr. James Freeman (5 minutes)
  • Advancement of blood-based biomarkers in neurologic conditions (25 minutes)
  • Introduction of NfL as the first CE-marked (CE 0197) blood-based biomarker for RMS (25 min)
  • Extro: Dr. James Freeman (5 minutes)

Learning Objectives

  • Gain a comprehensive understanding of the current and future neurologic blood-based biomarkers. 
  • Understanding the integration of NfL into laboratory practice and the clinic for RMS.
EuroMedLab 2025